CLOROX CO /DE/
AI Executive Summary
AI-powered analysis of 10-K filing content
Clorox reported a 26% decline in diluted EPS for fiscal 2026, driven by lower net sales, higher manufacturing and logistics costs, and ERP-related sales timing distortions. While the company completed a strategic acquisition of GOJO (Purell) to expand into B2B health and hygiene markets, near-term financial performance deteriorated amid macroeconomic headwinds and operational disruption from its new ERP system rollout.
Red Flags Detected (5)
Diluted EPS declined 26% year-over-year
Organic sales and earnings decreased in fiscal 2026
ERP system implementation caused 'expected near-term disruption' and distorted sales timing (pulled sales into prior year ahead of consumption)
2 more red flags detected
Key Takeaways
Net sales were $6.7 billion for FY2026 with ~9,200 employees globally
Over 80% of sales come from #1 or #2 market share brands, indicating strong competitive positioning despite near-term softness
3 more takeaways
Filing Overview
What This Means
Deteriorating Trend: Conditions are worsening compared to previous filings. This may create opportunities for service providers.
Annual Report: Comprehensive filing covering the full fiscal year with audited financial statements.